Miacalcic 100 IU/ml injection
Generic: Salmon Calcitonin
Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated September 7, 2024.
Generic: Salmon Calcitonin
Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated September 7, 2024.
Sorted by price per injection. Ask your pharmacist before you switch brands.
Prices as listed on BestinMeds.
Advertisement
What this medicine is for, how to take it, and what to watch for.
Read the full Salmon Calcitonin guide
Post-menopausal osteoporosis Salmon Calcitonin is indicated in Active Paget's disease in patients who do not respond to alternative treatments or for whom such treatments are not suitable; Hypercalcaemia.
Intravenous (Adult)- Emergency treatment of hypercalcaemia: Up to 10 u/kg in 500 mL of sodium chloride 0.9% by slow IV infusion over at least 6 hr. Parenteral (Adult)- Adjunct in hypercalcaemia: SC/IM: 4 u/kg 12 hrly, may increase after 1-2 days to 8 u/kg 12 hrly to max 8 u/kg 6 hrly after 2 days. Alternatively, 100 u every 6-8 hr, increased after 1-2 days to max 400 u every 6-8 hr. Paget's disease of bone: SC/IM: 50 u 3 times wkly to 100 u/day. Nasal (Adult)- Nasal postmenopausal osteoporosis: 200 u/day, alternation nostrils everyday.
GI disturbances, dizziness, flushing, tingling of the hands, unpleasant taste, skin rash, abdominal pain, urinary frequency, tremor, inj site inflammation. Rarely, diabetogenic effect.
Skin test should be done before initiating therapy. Heart failure; renal impairment. Pregnancy, lactation, childn.
Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Calcitonin is a polypeptide hormone produced by the ultimobranchial gland in non-mammalian vertebrates or by the mammalian thyroid parafollicular cells. It inhibits osteoclastic bone resorption and reduces bone turnover. It decreases tubular reabsorption and promotes renal excretion of Ca, Cl, Na, Mg, K and phosphate.
Concurrent use wth cardiac glycosides (e.g. digitalis) or Ca-channel blockers requires dosage adjustments of these drugs. May decrease serum concentration of lithium.
Renal Impairment: Dosage adjustment needed.
Symptoms: Flushing, nausea, vomiting and dizziness. Management: Symptomatic and supportive treatment.
Hormone in bone formation by Inhibiting bone resorption
Store between 2-8° C.
BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.
Advertisement
No other Miacalcic products are listed yet.
Advertisement